Jim Cramer prefers Bristol-Myers Squibb over Merck due to promising schizophrenia drug

From Yahoo Finance: 2025-05-01 14:58:00

In a recent analysis of 10 Jim Cramer stocks to watch amid Trump tariff wars, Bristol-Myers Squibb Company (BMY) stands out. Cramer discussed signs of de-escalation in US-China trade wars, mentioning bear market rallies as positive indicators. He also noted President Trump’s stance on Fed Chair Jerome Powell, dismissing the possibility of firing him. Cramer expressed preference for BMY over Merck due to its promising schizophrenia drug, ranking it 5th on the list. While BMY shows investment potential, under the radar AI stocks may offer higher returns in a shorter time frame. Check out our report on an undervalued AI stock with massive upside potential.



Read more at Yahoo Finance: Jim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia Drug